Meclizine Hydrochloride Tablets recall
FDA recall D-0418-2026 · initiated Mar 16, 2026
Amerisource Health Services LLC recalled Meclizine Hydrochloride Tablets in Mar 2026 — an FDA Class II recall (D-0418-2026) because Failed tablet specifications.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Failed tablet specifications.
The manufacturing process itself
The FDA found the process itself out of compliance, usually before any defective product was identified.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 697 cartons
Details
- Product
- Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
- Recalling company
- Amerisource Health Services LLC
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- U.S. Nationwide
- Initiated
- Mar 16, 2026
- FDA report date
- Apr 1, 2026
Frequently asked
- Was Meclizine Hydrochloride Tablets recalled?
- Amerisource Health Services LLC recalled Meclizine Hydrochloride Tablets in Mar 2026 — an FDA Class II recall (D-0418-2026) because Failed tablet specifications. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Meclizine Hydrochloride Tablets recalled?
- Per the FDA enforcement record, the reason for recall D-0418-2026 was: Failed tablet specifications.
- Is a recalled Meclizine Hydrochloride Tablets dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Meclizine Hydrochloride Tablets are affected?
- Distributed: U.S. Nationwide. The recall covers these lots — Lot #1024852; Exp 9/30/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0418-2026.